Alimentary Pharmacology & Therapeutics

Review article: acid suppression in non-variceal acute upper gastrointestinal bleeding
pp. 1565-1584(20)
Authors: Barkun,; Cockeram,; Plourde,; Fedorak,

Review article: cardiac adverse effects of gastrointestinal prokinetics
pp. 1585-1591(7)
Authors: Tonini,; De Ponti,; Di Nucci,; Crema,

Ursodeoxycholic acid has no influence on function after restorative proctocolectomy in ulcerative colitis
pp. 1593-1596(4)
Authors: Tan,; Morton,; Bain,; Keighley,

A randomized dose-response and pharmacokinetic study of methotrexate for refractory inflammatory Crohn's disease and ulcerative colitis
pp. 1597-1604(8)
Authors: Egan,; Sandborn,; Tremaine,; Leighton,; Mays,; Pike,; Zinsmeister,; Lipsky,

Onset of action during on-demand treatment with Maalox suspension or low-dose ranitidine for heartburn
pp. 1605-1610(6)
Authors: Faaij,; Van Gerven,; Jolivet-Landreau,; Masclee,; Vendrig,; Schoemaker,; Jacobs,; Cohen,

Standard-dose lansoprazole is more effective than high-dose ranitidine in achieving endoscopic healing and symptom relief in patients with moderately severe reflux oesophagitis
pp. 1611-1620(10)
Authors: Jansen,; Van Oene,

Complete resolution of heartburn symptoms and health-related quality of life in patients with gastro-oesophageal reflux disease
pp. 1621-1630(10)
Authors: Revicki,; Crawley,; Zodet,; Levine,; Joelsson,

Impact of advertisement and clinic populations in symptoms and perception of irritable bowel syndrome
pp. 1631-1638(8)
Authors: Lee,; Fitzgerald,; Naliboff,; Schmulson,; Liu,; Fullerton,; Mayer,; Chang,

Efficacy of two different dosage regimens of omeprazole, amoxycillin and metronidazole for the cure of Helicobacter pylori infection
pp. 1639-1645(7)
Authors: Bayerdörffer,; Lonovics,; Dité,; Díete,; Domján,; Kisfalvi,; Mégraud,; Pap,; Sipponen,; Burman,; Zeijlon,

Omeprazole, clarithromycin and furazolidone for the eradication of Helicobacter pylori in patients with duodenal ulcer
pp. 1647-1652(6)
Authors: Dani,; Queiroz,; Dias,; Franco,; Magalhães,; Mendes,; Moreira,; De Castro,; Toppa,; Rocha,; Cabral,; Salles,

Non-steroidal anti-inflammatory drugs inhibit Helicobacter pylori-induced human neutrophil reactive oxygen metabolite production in vitro
pp. 1653-1661(9)
Authors: Jones-Blackett,; Hull,; Davies,; Crabtree,

Behaviour of Saccharomyces boulardii in recurrent Clostridium difficile disease patients
pp. 1663-1668(6)
Authors: Elmer,; McFarland,; Surawicz,; Danko,; Greenberg,

Nα-methyl histamine and histamine stimulate gastrin release from rabbit G-cells via histamine H₂-receptors
pp. 1669-1674(6)
Authors: Bliss,; Healey,; Arebi,; Calam,

N-bisphosphonates cause gastric epithelial injury independent of effects on the microcirculation
pp. 1675-1682(8)
Authors: Wallace,; Dicay,; Mcknight,; Bastaki,; Blank,

Endogenous nitric oxide in the regulation of gastric secretory and motor activity in humans
pp. 1683-1691(9)
Authors: Konturek,; Fischer,; Gromotka,; Domschke,

The importance of clarithromycin dose in the management of H. pylori infection: a meta-analysis of triple therapies with a proton pump inhibitor, clarithromycin and amoxycillin or metronidazole
pp. 1693-1693(1)
Author: Harris,

Reply—The importance of clarithromycin dose in the management of H. pylori infection: a meta-analysis of triple therapies with a proton pump inhibitor, clarithromycin and amoxycillin or metronidazole
pp. 1693-1694(2)
Authors: Huang,; Hunt,